News and Events

We are thrilled to share our conference lineup for February through June! Chemspace is gearing up for an incredible start to 2025. Here’s where you can find us.

We at Chemspace are thrilled to join EFPIA and its “Partners in Research” initiative!  

In 2024, Microtubule-Associated Protein Tau (MAPT) has been a major focus in neurodegeneration research. To support advancements in this field, we have curated a set of Chemspace Biologics.

By using advanced computing solutions and our collaboration with Fovus, we optimize complex simulations without compromising on speed or accuracy. The result? More reliable predictions and better-targeted compound selections.

We are excited to announce the launch of our brand-new Biologics webpage on Chemspace’s website! 

Happy New Year! Now, let’s take a look back at some of the key milestones we achieved together in 2024.

2024 brought its share of challenges, but thanks to your support and trust, it was also a year of growth, learning, and teamwork.

TRPV1, a key target for new analgesics, mediates pain signaling, neuroinflammation, and more. Explore its role with our curated Chemspace Biologics set!

Discover the potential of the 2,7-diazaspiro[3.5]nonane core! Inspired by revumenib, we offer building blocks featuring this unique fragment for your drug discovery needs.

This year was amazing for our Drug Discovery team! We took on big challenges, hit exciting milestones, and made great progress. Let’s look back at what we achieved!

Last week, Enamine and Elsevier announced a collaboration to integrate 43 million MADE analog compounds into Reaxys, enhancing resources for chemical discovery!

Check out the video to see the highlights from the conferences we attended this year!  

We are summarizing the latest updates from Chemspace! Check out our November posts!

Freedom Space 3.0 is now available for synthon-based search via the RDKit library!

We at Chemspace have come a long way from the launch of the platform for searching and purchasing small molecules to the creation of the drug discovery platform. Let's take a look at how we have grown over the past decade!

Until December 31, 2024, Chemspace offers an exclusive discount of up to 10% on compounds from Enamine REAL and Freedom Space 3.0.

Today, we invite you to focus on Interleukin-17 (IL-17), a promising therapeutic target for treating numerous inflammatory and autoimmune diseases.

This year, the FDA approved aprocitentan (TRYVIO™), a first-in-class dual endothelin A/endothelin B (ETA/ETB) receptor antagonist for the treatment of resistant hypertension.

Let’s introduce our Sourcing Manager – Anna Borovska! Today, Anna is sharing a bit about her hobbies and passions.

Discover analogs for Compound 2 - dual LSD1-HDAC inhibitor - a promising therapy for colorectal cancer (CRC). Compound 2 has demonstrated impressive anti-cancer activity, suppressing the growth of CRC cells while significantly reducing colony formation and inducing cell cycle arrest.

We are summarizing the latest updates from Chemspace! Check out our October posts!

We have updated Enamine REAL Space on our website, now offering easy access to over 75 billion molecules!

Don’t miss an exclusive 25% discount on specific Micro Fast ELISA kits, bringing unmatched efficiency to your research.

Exciting news! Our General Pre-Plated Library now features over 917K screening compounds!

We’re thrilled to present you with an exclusive opportunity to unlock the full potential of DNA-Encoded Libraries at an incredible price!